Printer Friendly

DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES HIGHER SECOND QUARTER AND FIRST HALF RESULTS

 DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES
 HIGHER SECOND QUARTER AND FIRST HALF RESULTS
 COLUMBUS, Ohio, Aug. 6 /PRNewswire/ -- Danninger Medical Technology, Inc. (NASDAQ: DANN) today announced net income of $188,632 for the six months ended June 30, 1992, compared to $5,779 a year ago. On an earnings per share basis, these results represent 4 cents versus 0 cents for the same periods in 1992 and 1991, respectively. Total revenue for the first six months of 1992 increased to $4,108,301 from $3,932,810 last year.
 For the three months ended June 30, 1992, net income was $33,321, or 1 cent per share, compared to a loss of $102,132, or 2 cents per share, last year. Total revenues for the three months ended June 30, 1992 rose to $1,993,169 from $1,927,470 a year ago. The company recently established its own regional sales force for spinal devices to improve sales coverage and maintain closer contact with surgeons using the devices.
 The second quarter results benefitted from additional dealers in the specialty lease program for recovery products, lower cost of sales and a
material recovery of doubtful accounts. Progress continues to be realized as a result of specific changes in distribution of the company's products. These efforts were further strengthened recently through the addition of sales and marketing vice presidents, with extensive industry experience, for both divisions. In addition, a medical advisory board was established to develop new spinal devices for Cross Medical Products, Inc., a wholly-owned subsidiary.
 Danninger Medical Technology, Inc. designs, manufactures, and markets medical devices that assist patients in their recovery following surgery or trauma. Danninger is a leader in Continuous Passive Motion devices for the knee, hip and hand. Cross Medical Products, Inc. manufactures and markets orthopedic surgical devices and instrumentation, as well as a spinal implant subject to an FDA Investigational Device Exemption.
 FINANCIAL HIGHLIGHTS
 Six Months Ended Six Months Ended
 June 30, 1992 June 30, 1991
 Total Revenues $4,108,301 $3,932,810
 Net Income $ 188,632 $ 5,779
 Earnings Per Share $ .04 $ .00
 Three Months Ended Three Months Ended
 June 30, 1992 June 30, 1991
 Total Revenues $1,993,169 $1,927,470
 Net (Loss) Income $ 33,321 $ (102,132)
 Earnings Per Share $ .01 $ (.02)
 June 30, 1992 Dec. 31, 1991
 Total Assets $7,932,994 $6,955,027
 Working Capital $3,588,465 $3,509,265
 Shareholders' Equity $3,951,678 $3,745,193
 -0- 8/6/92
 /CONTACT: Joseph A. Mussey, president of Danninger Medical Technology, Inc., 614-276-8267/
 (DANN) CO: Danninger Medical Technology, Inc. ST: Ohio IN: MTC SU: ERN


BM -- CL019 -- 7600 08/06/92 12:24 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 6, 1992
Words:445
Previous Article:FITCH PLACES ILLINOIS POWER PREFERRED ON ALERT; NEGATIVE IMPLICATIONS -- FITCH FINANCIAL WIRE --
Next Article:INTEGON CORPORATION DECLARES DIVIDEND
Topics:


Related Articles
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES 1992 RESULTS
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES IMPROVED SECOND QUARTER RESULTS
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES HIGHER THIRD QUARTER REVENUES AND IMPROVED RESULTS
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES RECORD SALES FOR 1993; NET LOSS DUE TO PROVISIONS FOR CERTAIN INVENTORY AND ACCOUNTS RECEIVABLE
DANNINGER MEDICAL TECHNOLOGY ANNOUNCES FIRST QUARTER RESULTS
DANNINGER MEDICAL TECHNOLOGY, INC. REPORTS IMPROVED SALES, NET INCOME FOR FOURTH QUARTER, FULL YEAR 1994
DANNINGER MEDICAL TECHNOLOGY, INC. REPORTS RECORD FIRST QUARTER SALES
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES IMPROVED SECOND QUARTER RESULTS
DANNINGER MEDICAL TECHNOLOGY, INC. REPORTS RECORD FIRST QUARTER SALES
Danninger Medical Announces Preliminary Results for The Fourth Quarter and For The Year

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters